Anti-lymphangiogenesis effects of a specific anti-interleukin 7 receptor antibody in lung cancer model in vivo

Molecular Carcinogenesis

Volumn 54, Issue 2, 2015, Pages 148-155

  Jian, Ming ^a   Qingfu, Zhang ^b   Yanduo, Jiang ^a   Guocheng, Jiang ^a   Xueshan, Qiu ^b  

^a No 202 Hospital of PLA   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

In vivo; Interleukin 7; Interleukin 7 receptor; Lung cancer; Lymphangiogenesis

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYTOKINE RECEPTOR ANTAGONIST; DNA; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; MESSENGER RNA; PROTEIN C FOS; PROTEIN C JUN; RECOMBINANT INTERLEUKIN 7; SC 13085; SC 662; UNCLASSIFIED DRUG; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN INHIBITOR; ANTIBODY;

A-549 CELL LINE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DOSE COMPARISON; DRUG EFFICACY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LUNG CANCER; LYMPHANGIOGENESIS; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PROTEIN ANALYSIS; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CANCER TRANSPLANTATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIBODIES; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-7; LUNG NEOPLASMS; LYMPHANGIOGENESIS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RECEPTORS, INTERLEUKIN-7; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 84920624431     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22082     Document Type: Article

References (25)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90.
2. Achen MG, McColl BK, Stacker SA. Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 2005; 7:121-127.
3. Tobler NE, Detmar M. Tumor and lymph node lymphangiogenesis-Impact on cancer metastasis. J Leukoc Biol 2006; 80:691-696.
4. Ungefroren H, Sebens S, Seidl D, Lehnert H, Hass R. Interaction of tumor cells with the microenvironment. Cell Commun Signal 2011; 9:18-25.
5. Fidler IJ. The biology of cancer metastasis. Semin Cancer Biol 2011; 21:71.
6. Tammela T, Alitalo K. Lymphangiogenesis: Molecular mechanisms and future promise. Cell 2010; 140:460-476.
7. Cao Y. Opinion: Emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer 2005; 5:735-743.
8. Duong T, Koopman P, Francois M. Tumor lymphangiogenesis as a potential therapeutic target. J Oncol 2012; 2012:204946.
9. Shayan R, Achen MG, Stacker SA. Lymphatic vessels in cancer metastasis: Bridging the gaps. Carcinogenesis 2006; 27:1729-1738.
10. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002; 2:573-583.
11. Karpanen T, Alitalo K. Molecular biology and pathology of lymphangiogenesis. Annu Rev Pathol 2008; 3:367-397.
12. Lohela M, Bry M, Tammela T, Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 2009; 21:154-165.
13. Davydova N, Streltsov VA, Roufail S, et al. Preparation of human vascular endothelial growth factor-D for structural and preclinical therapeutic studies. Protein Expr Purif 2012; 82:232-239.
14. Jeltsch M, Kaipainen A, Joukov V, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 1997; 276:1423-1425.
15. Karnezis T, Shayan R, Caesar C, et al. VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. Cancer Cell 2012; 21:181-195.
16. Enholm B, Karpanen T, Jeltsch M, et al. Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ Res 2001; 88:623-629.
17. Byzova TV, Goldman CK, Jankau J, et al. Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo. Blood 2002; 99:4434-4442.
18. Foxwell BMJ, Beadling C, Guschin D, Kerr I, Cantrell D. Interleukin-7 can induce the activation of JAK-1, JAK-3 and STAT-5 proteins in murine T cells. Eur J Immunol 1995; 25:3041-3046.
19. Ming J, Zhang Q, Qiu X, Wang E. Interleukin 7/interleukin 7 receptor induce c-Fos/c-Jun-dependent vascular endothelial growth factor-D up-regulation: A mechanism of Lymphangiogenesis in lung cancer. Eur J Cancer 2009; 45:866-873.
20. de Oliveira AT, Reis RM, Afonso J, et al. Lymphangiogenic VEGF-C and VEGFR-3 expression in genetically characterised gastrointestinal stromal tumours. Histol Histopathol 2011; 26:1499-1507.
21. Zampell JC, Avraham T, Yoder N, et al. Lymphatic function is regulated by a coordinated expression of lymphangiogenic and anti-lymphangiogenic cytokines. Am J Physiol Cell Physiol 2012; 302:C392-C404.
22. Shinriki S, Jono H, Ueda M, et al. Interleukin-6 signalling regulates vascular endothelial growth factor-C synthesis and lymphangiogenesis in human oral squamous cell carcinoma. J Pathol 2011; 225:142-150.
23. Raica M, Cimpean AM, Ceausu R, Ribatti D. Lymphatic microvessel density, VEGF-C, and VEGFR-3 expression in different molecular types of breast cancer. Anticancer Res 2011; 31:1757-1764.
24. Kozlowski M, Naumnik W, Niklinski J, et al. Vascular endothelial growth factor C and D expression correlates with lymph node metastasis and poor prognosis in patients with resected esophageal cancer. Neoplasma 2011; 58:311-319.
25. Karpanen T, Wirzenius M, Makinen T, et al. Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation. Am J Pathol 2006; 169:708-718.